Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-x4r87 Total loading time: 0 Render date: 2024-04-29T23:42:48.281Z Has data issue: false hasContentIssue false

Chap. 9 - LIFE-THREATENING BACTERIAL SKIN INFECTIONS

Published online by Cambridge University Press:  07 September 2011

By
Richard B. Cindrich  and
Donald Rudikoff
Edited by
Ronni Wolf ,
Batya B. Davidovici ,
Jennifer L. Parish  and
Lawrence Charles Parish
Richard B. Cindrich
Affiliation:
Albert Einstein College of Medicine
Donald Rudikoff
Affiliation:
Albert Einstein College of Medicine
Ronni Wolf
Affiliation:
Kaplan Medical Center, Rehovot, Israel
Batya B. Davidovici
Affiliation:
Kaplan Medical Center, Rehovot, Israel
Jennifer L. Parish
Affiliation:
Jefferson Medical College of Thomas Jefferson University
Lawrence Charles Parish
Affiliation:
Jefferson Medical College of Thomas Jefferson University
Get access

Summary

DERMATOLOGISTS are often called on to diagnose severe life-threatening skin infections in the emergency department, hospital wards, and in their clinical practices. The observational skills of the dermatologic specialist enable him or her to differentiate conditions that are potentially fatal from those that may look horrific but are not life threatening. This chapter provides essential information on serious infections, many of which are not usually discussed in depth in most dermatologic texts. These include periorbital (preseptal) and orbital cellulitis, malignant external otitis, meningococcemia, Rocky Mountain spotted fever (RMSF), Mediterranean spotted fever, anthrax, tularemia, and infections with Vibrio vulnificus, Aeromonas hydrophila and Chromobacterium violaceum. It is hoped that prompt recognition of these infections by the clinician will reduce morbidity and possibly be lifesaving.

PERIORBITAL (PRESEPTAL) CELLULITIS AND ORBITAL CELLULITIS

Background

Eyelid infections presenting with erythema and edema are not uncommon in children and adults and in some cases can cause serious sequelae. Involvement of the orbit with bacterial infection can result in severe damage to the eye, cavernous sinus thrombosis, and death. Preseptal cellulitis is an infection of the eyelids and surrounding skin anterior to the orbital septum (Figure 9.1). This layer of fibrous tissue arises from the periosteum of the orbit and extends into the eyelids. Infection posterior to the septum is referred to as orbital cellulitis. Although less common than preseptal cellulitis, it is a much more worrisome condition with the potential for major sequelae.

Type
Chapter
Information
Emergency Dermatology , pp. 81 - 97
Publisher: Cambridge University Press
Print publication year: 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Carlisle, RT, Fredrick, GT. Preseptal and orbital cellulitis. Hosp Physician. 2006; 42:15–19.Google Scholar
Givner, LB. Periorbital versus orbital cellulitis. Pediatr Infect Dis J. 2002; 21:1157–8.CrossRefGoogle ScholarPubMed
Sobol, AL, Hutcheson, KA. Cellulitis, preseptal. WebMD; 2008 [updated April 4, 2008; cited 2008 June 29, 2008]; Available from: http://www.emedicine.com/oph/topic206.htm.
Al-Nammari, S, Roberton, B, Ferguson, C. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Should a child with preseptal periorbital cellulitis be treated with intravenous or oral antibiotics?Emerg Med J. 2007; 24:128–9.CrossRefGoogle ScholarPubMed
Reynolds, DJ, Kodsi, SR, Rubin, SE, Rodgers, IR. Intracranial infection associated with preseptal and orbital cellulitis in the pediatric patient. J AAPOS. 2003; 7:413–17.CrossRefGoogle ScholarPubMed
Rubin Grandis, J, Branstetter, BF 4th, Yu, VL. The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations. Lancet Infect Dis. 2004; 4:34–9.CrossRefGoogle ScholarPubMed
Weinroth, SE, Schessel, D, Tuazon, CU. Malignant otitis externa in AIDS patients: case report and review of the literature. Ear Nose Throat J. 1994; 73:772–4, 7–8.Google ScholarPubMed
Rubin, J, Yu, VL, Stool, SE. Malignant external otitis in children. J Pediatr. 1988; 113:965–70.CrossRefGoogle ScholarPubMed
Grandis, JR, Curtin, HD, Yu, VL. Necrotizing (malignant) external otitis: prospective comparison of CT and MR imaging in diagnosis and follow-up. Radiology. 1995; 196:499–504.CrossRefGoogle Scholar
Levenson, MJ, Parisier, SC, Dolitsky, J, Bindra, G.Ciprofloxacin: drug of choice in the treatment of malignant external otitis (MEO). Laryngoscope. 1991; 101:821–4.CrossRefGoogle Scholar
Rubin, J, Stoehr, G, Yu, VL, et al. Efficacy of oral ciprofloxacin plus rifampin for treatment of malignant external otitis. Arch Otolaryngol Head Neck Surg. 1989; 115:1063–9.CrossRefGoogle ScholarPubMed
Bernstein, JM, Holland, NJ, Porter, GC, Maw, AR. Resistance of Pseudomonas to ciprofloxacin: implications for the treatment of malignant otitis externa. J Laryngol Otol. 2007; 121:118–23.CrossRefGoogle ScholarPubMed
Berenholz, L, Katzenell, U, Harell, M. Evolving resistant pseudomonas to ciprofloxacin in malignant otitis externa. Laryngoscope. 2002; 112:1619–22.CrossRefGoogle ScholarPubMed
Carfrae, MJ, Kesser, BW. Malignant otitis externa. Otolaryngol Clin North Am. 2008; 41:537–49, viii–ix.CrossRefGoogle ScholarPubMed
Phillips, JS, Jones, SE. Hyperbaric oxygen as an adjuvant treatment for malignant otitis externa. Cochrane Database Syst Rev. 2005(2):CD004617.Google Scholar
Soudry, E, Joshua, BZ, Sulkes, J, Nageris, BI. Characteristics and prognosis of malignant external otitis with facial paralysis. Arch Otolaryngol Head Neck Surg. 2007; 133:1002–4.CrossRefGoogle ScholarPubMed
Chandler, JR. Malignant external otitis. Laryngoscope. 1968; 78:1257–94.CrossRefGoogle ScholarPubMed
Lucente, FE, Parisier, SC. James, R. Chandler: “Malignant external otitis.” (Laryngoscope. 1968; 78:1257–94). Laryngoscope. 1996; 106:805–7.CrossRefGoogle Scholar
Kimmelman, CP, Lucente, FE. Use of ceftazidime for malignant external otitis. Ann Otol Rhinol Laryngol. 1989; 98:721–5.CrossRefGoogle ScholarPubMed
Meyers, BR, Mendelson, MH, Parisier, SC, Hirschman, SZ. Malignant external otitis. Comparison of monotherapy vs combination therapy. Arch Otolaryngol Head Neck Surg. 1987; 113:974–8.CrossRefGoogle ScholarPubMed
Singh, A, Al Khabori, M, Hyder, MJ. Skull base osteomyelitis: diagnostic and therapeutic challenges in atypical presentation. Otolaryngol Head Neck Surg. 2005; 133:121–5.CrossRefGoogle ScholarPubMed
Shichmanter, R, Miller, EB, Landau, Z. Adverse drug reactions due to prolonged antibiotic therapy for malignant external otitis. Eur J Intern Med. 2004; 15:441–5.CrossRefGoogle ScholarPubMed
Mani, N, Sudhoff, H, Rajagopal, S, et al. Cranial nerve involvement in malignant external otitis: implications for clinical outcome. Laryngoscope. 2007; 117:907–10.CrossRefGoogle ScholarPubMed
Rosenstein, NE, Perkins, BA. Update on Haemophilus influenzae serotype b and meningococcal vaccines. Pediatr Clin North Am. 2000; 47:337–52, vi.CrossRefGoogle ScholarPubMed
Healy, CM, Baker, CJ. The future of meningococcal vaccines. Pediatr Infect Dis J. 2005; 24:175–6.CrossRefGoogle ScholarPubMed
Jackson, , Wenger, JD. Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989–1991. MMWR CDC Surveill Summ. 1993; 4;42:21–30.Google Scholar
Stephens, DS, Hajjeh, RA, Baughman, WS, et al. Sporadic meningococcal disease in adults: results of a 5-year population-based study. Ann Intern Med. 1995; 123:937–40.CrossRefGoogle ScholarPubMed
Yung, AP, McDonald, MI. Early clinical clues to meningococcaemia. Med J Aust. 2003; 178:134–7.Google ScholarPubMed
Braverman, IM. Skin signs of systemic disease. 2nd ed. Philadelphia: WB Saunders; 1981, p. 816.Google Scholar
Thompson, MJ, Ninis, N, Perera, R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006; 4:367:397–403.Google Scholar
Kirsch, EA, Barton, RP, Kitchen, L, Giroir, BP. Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience. Pediatr Infect Dis J. 1996; 15:967–78; quiz 79.CrossRefGoogle ScholarPubMed
Milonovich, LM. Meningococcemia: epidemiology, pathophysiology, and management. J Pediatr Health Care. 2007; 21:75–80.CrossRefGoogle ScholarPubMed
Ferreira, E, Dias, R, Canica, M. Antimicrobial susceptibility, serotype and genotype distribution of meningococci in Portugal, 2001–2002. Epidemiol Infect. 2006; 134:1203–7.CrossRefGoogle Scholar
Kyaw, MH, Clarke, SC, Christie, P, et al. Invasive meningococcal disease in Scotland, 1994 to 1999, with emphasis on group B meningococcal disease. J Clin Microbiol. 2002; 40:1834–7.CrossRefGoogle ScholarPubMed
Jackson, , Tenover, FC, Baker, C, et al. Prevalence of Neisseria meningitidis relatively resistant to penicillin in the United States, 1991. Meningococcal Disease Study Group. J Infect Dis. 1994; 169:438–41.CrossRefGoogle ScholarPubMed
Rosenstein, NE, Perkins, BA, Stephens, DS, et al. Meningococcal disease. N Engl J Med. 2001; 344:1378–88.CrossRefGoogle ScholarPubMed
Swartz, MN. Bacterial meningitis–a view of the past 90 years. N Engl J Med. 2004; 351:1826–8.CrossRefGoogle ScholarPubMed
Durand, ML, Calderwood, SB, Weber, DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. 1993; 328:21–8.CrossRefGoogle ScholarPubMed
Sharip, A, Sorvillo, F, Redelings, MD, et al. Population-based analysis of meningococcal disease mortality in the United States: 1990–2002. Pediatr Infect Dis J. 2006; 25:191–4.CrossRefGoogle ScholarPubMed
Gondim, FA, Singh, MK. Meningococcal meningitis. WebMD; 2007 [updated 2007; cited July 18, 2008]; Available from: http://www.emedicine.com/neuro/topic210.htm.
Beek, D, Gans, J, McIntyre, P, Prasad, K. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2007(1):CD004405.Google Scholar
Dumler, JS, Walker, DH. Rocky Mountain spotted fever–changing ecology and persisting virulence. N Engl J Med. 2005; 353:551–3.CrossRefGoogle ScholarPubMed
Chapman, AS, Murphy, SM, Demma, LJ, et al. Rocky Mountain spotted fever in the United States, 1997–2002. Ann N Y Acad Sci. 2006; 1078:154–5.CrossRefGoogle ScholarPubMed
McNabb, SJ, Jajosky, RA, Hall-Baker, PA, et al. Summary of notifiable diseases–United States, 2006. MMWR Morb Mortal Wkly Rep. 2008; 55:1–92.Google ScholarPubMed
Hopkins, RS, Jajosky, RA, Hall, PA, et al. Summary of notifiable diseases–United States, 2003. MMWR Morb Mortal Wkly Rep. 2005; 52:1–85.Google ScholarPubMed
Lacz, NL, Schwartz, RA, Kapila, R.Rocky Mountain spotted fever. J Eur Acad Dermatol Venereol. 2006; 20:411–7.CrossRefGoogle ScholarPubMed
Dantas-Torres, F.Rocky Mountain spotted fever. Lancet Infect Dis. 2007; 7:724–32.CrossRefGoogle ScholarPubMed
Buckingham, SC, Marshall, GS, Schutze, GE, et al. Clinical and laboratory features, hospital course, and outcome of Rocky Mountain spotted fever in children. J Pediatr. 2007; 150:180–4.CrossRefGoogle ScholarPubMed
Cunha, BA. Clinical features of Rocky Mountain spotted fever. Lancet Infect Dis. 2008; 8:143–4.CrossRefGoogle ScholarPubMed
Bleck, TP. Central nervous system involvement in Rickettsial diseases. Neurol Clin. 1999; 17:801–12.CrossRefGoogle ScholarPubMed
Abrahamian, FM. Consequences of delayed diagnosis of Rocky Mountain spotted fever in children–West Virginia, Michigan, Tennessee, and Oklahoma, May–July 2000. Ann Emerg Med. 2001; 37:537–40.CrossRefGoogle Scholar
Lochary, ME, Lockhart, PB, Williams, WT. Doxycycline and staining of permanent teeth. Pediatr Infect Dis J. 1998; 17:429–31.CrossRefGoogle ScholarPubMed
Markley, KC, Levine, AB, Chan, Y. Rocky Mountain spotted fever in pregnancy. Obstet Gynecol. 1998; 91:860.Google ScholarPubMed
Dalton, MJ, Clarke, MJ, Holman, RC, et al. National surveillance for Rocky Mountain spotted fever, 1981–1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg. 1995; 52:405–13.CrossRefGoogle ScholarPubMed
Helmick, CG, Bernard, KW, D'Angelo, LJ. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis. 1984; 150:480–8.CrossRefGoogle ScholarPubMed
Hattwick, MA, Retailliau, H, O'Brien, RJ, et al. Fatal Rocky Mountain spotted fever. JAMA. 1978; 240:1499–503.CrossRefGoogle ScholarPubMed
Cohen, JI, Corson, AP, Corey, GR. Late appearance of skin rash in Rocky Mountain spotted fever. South Med J. 1983; 76:1457–8.CrossRefGoogle ScholarPubMed
Kirkland, KB, Wilkinson, WE, Sexton, DJ. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis. 1995; 20:1118–21.CrossRefGoogle ScholarPubMed
Conlon, PJ, Procop, GW, Fowler, V, et al. Predictors of prognosis and risk of acute renal failure in patients with Rocky Mountain spotted fever. Am J Med. 1996; 101:621–6.CrossRefGoogle ScholarPubMed
Walker, DH, Kirkman, HN. Rocky Mountain spotted fever and deficiency in glucose-6-phosphate dehydrogenase. J Infect Dis. 1980; 142:771.CrossRefGoogle ScholarPubMed
Bergeron, JW, Braddom, RL, Kaelin, DL. Persisting impairment following Rocky Mountain spotted fever: a case report. Arch Phys Med Rehabil. 1997; 78:1277–80.CrossRefGoogle ScholarPubMed
,Textbook of military medicine. Part III, Disease and the environment. Falls Church, VA: Office of the Surgeon General, Dept. of the Army, U.S. of America; 1993.Google Scholar
Keysary, A, Potasman, I, Itzhaki, A, et al. Clusters of Mediterranean spotted fever in Israel. Vector Borne Zoonotic Dis. 2007; 7:143–6.CrossRefGoogle ScholarPubMed
Brouqui, P, Parola, P, Fournier, PE, Raoult, D.Spotted fever rickettsioses in southern and eastern Europe. FEMS Immunol Med Microbiol. 2007; 49:2–12.CrossRefGoogle ScholarPubMed
Sousa, R, Nobrega, SD, Bacellar, F, Torgal, J. Mediterranean spotted fever in Portugal: risk factors for fatal outcome in 105 hospitalized patients. Ann N Y Acad Sci. 2003; 990:285–94.CrossRefGoogle ScholarPubMed
Raoult, D, Micco, C, Gallais, H, Toga, M. Laboratory diagnosis of Mediterranean spotted fever by immunofluorescent demonstration of Rickettsia conorii in cutaneous lesions. J Infect Dis. 1984; 150:145–8.CrossRefGoogle ScholarPubMed
Dujella, J, Morovic, M, Dzelalija, B, et al. Histopathology and immunopathology of skin biopsy specimens in Mediterranean spotted fever. Acta Virol. 1991; 35:566–72.Google ScholarPubMed
Bella, F, Espejo, E, Uriz, S, et al. J. Randomized trial of 5-day rifampin versus 1-day doxycycline therapy for Mediterranean spotted fever. J Infect Dis. 1991; 164:433–4.CrossRefGoogle Scholar
Cascio, A, Colomba, C, Antinori, S, et al. Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial. Clin Infect Dis. 2002; 34:154–8.CrossRefGoogle ScholarPubMed
Cascio, A, Colomba, C, Di Rosa, D, et al. Efficacy and safety of clarithromycin as treatment for Mediterranean spotted fever in children: a randomized controlled trial. Clin Infect Dis. 2001; 33:409–11.CrossRefGoogle ScholarPubMed
Raoult, D, Gallais, H, Micco, P, Casanova, P. Ciprofloxacin therapy for Mediterranean spotted fever. Antimicrob Agents Chemother. 1986; 30:606–7.CrossRefGoogle ScholarPubMed
Dixon, TC, Meselson, M, Guillemin, J, Hanna, PC. Anthrax. N Engl J Med. 1999; 341:815–26.CrossRefGoogle ScholarPubMed
Demirdag, K, Ozden, M, Saral, Y, et al. Cutaneous anthrax in adults: a review of 25 cases in the eastern Anatolian region of Turkey. Infection. 2003; 31:327–30.Google ScholarPubMed
Peck, RN, Fitzgerald, DW. Cutaneous anthrax in the Artibonite Valley of Haiti: 1992–2002. Am J Trop Med Hyg. 2007; 77:806–11.Google ScholarPubMed
Meyer, MA. Neurologic complications of anthrax: a review of the literature. Arch Neurol. 2003; 60:483–8.CrossRefGoogle ScholarPubMed
Swartz, MN. Recognition and management of anthrax–an update. N Engl J Med. 2001; 345:1621–6.CrossRefGoogle ScholarPubMed
Test shaving brush of anthrax victim: Health department to seek today for germ which killed Michael F. Farley. New York Times. 1921 October 10.
Anthrax is spread by street vendors: Bellevue experts find dreaded germs in cheap shaving brushes bought from peddlers. New York Times. 1922 January 22.
,Cutaneous anthrax associated with drum making using goat hides from west Africa–Connecticut, 2007. MMWR Morb Mortal Wkly Rep. 2008; 57:628–31.
Carucci, JA, McGovern, TW, Norton, SA, et al. Cutaneous anthrax management algorithm. J Am Acad Dermatol. 2002; 47:766–9.CrossRefGoogle ScholarPubMed
Artac, H, Silahli, M, Keles, S, et al. A rare cause of preseptal cellulitis: anthrax. Pediatr Dermatol. 2007; 24:330–1.CrossRefGoogle ScholarPubMed
Shieh, WJ, Guarner, J, Paddock, C, et al. The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax. Am J Pathol. 2003; 163:1901–10.CrossRefGoogle ScholarPubMed
Bode, E, Hurtle, W, Norwood, D. Real-time PCR assay for a unique chromosomal sequence of Bacillus anthracis. J Clin Microbiol. 2004; 42:5825–31.CrossRefGoogle ScholarPubMed
,Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Mortal Wkly Rep. 2001; 50:909–19.
Maguina, C, Flores Del Pozo, J, Terashima, A, et al. Cutaneous anthrax in Lima, Peru: retrospective analysis of 71 cases, including four with a meningoencephalic complication. Rev Inst Med Trop Sao Paulo. 2005; 47:25–30.CrossRefGoogle ScholarPubMed
Doganay, M, Bakir, M, Dokmetas, I. A case of cutaneous anthrax with toxaemic shock. Br J Dermatol. 1987; 117:659–62.CrossRefGoogle ScholarPubMed
Holty, JE, Bravata, DM, Liu, H, et al. Systematic review: a century of inhalational anthrax cases from 1900 to 2005. Ann Intern Med. 2006; 144:270–80.CrossRefGoogle ScholarPubMed
Eliasson, H, Back, E. Tularaemia in an emergent area in Sweden: an analysis of 234 cases in five years. Scand J Infect Dis. 2007; 39:880–9.CrossRefGoogle Scholar
,Tularemia transmitted by insect bites–Wyoming, 2001–2003. MMWR Morb Mortal Wkly Rep. 2005; 54:170–3.
Trevisanato, SI. The biblical plague of the Philistines now has a name, tularemia. Med Hypotheses. 2007; 69:1144–6.CrossRefGoogle Scholar
The holy scriptures according to the Masoretic text. Philadelphia: The Jewish Publication Society of America; 1955, p. 144.
Myers, JP, Baird, IM. Case report. Tularemia in Ohio: report of two cases and clinical review. Am J Med Sci. 1981; 282:148–52.CrossRefGoogle ScholarPubMed
Evans, ME, Gregory, DW, Schaffner, W, McGee, ZA. Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore). 1985; 64:251–69.CrossRefGoogle ScholarPubMed
Penn, RL. Fransicella tularensis. In: Mandell, GL, Douglas, RG, Bennett, JE, editors. Principles and practice of infectious diseases. 2nd ed. New York: Wiley; 1985; pp. 2060–8.Google Scholar
Byington, CL, Bender, JM, Ampofo, K, et al. Tularemia with vesicular skin lesions may be mistaken for infection with herpes viruses. Clin Infect Dis. 2008; 47:e4–6.CrossRefGoogle ScholarPubMed
Guffey, MB, Dalzell, A, Kelly, DR, Cassady, KA. Ulceroglandular tularemia in a nonendemic area. South Med J. 2007; 100:304–8.CrossRefGoogle Scholar
Weinberg, AN. Commentary: Wherry WB, Lamb BH. Infection of man with Bacterium tularense (J Infect Dis 1914; 15:331–40). J Infect Dis. 2004; 189:1317–20.CrossRefGoogle Scholar
Oliver, JD. Wound infections caused by Vibrio vulnificus and other marine bacteria. Epidemiol Infect. 2005; 133:383–91.CrossRefGoogle ScholarPubMed
Inoue, Y, Ono, T, Matsui, T, et al. Epidemiological survey of Vibrio vulnificus infection in Japan between 1999 and 2003. J Dermatol. 2008; 35:129–39.CrossRefGoogle ScholarPubMed
Kuo, YL, Shieh, SJ, Chiu, HY, Lee, JW. Necrotizing fasciitis caused by Vibrio vulnificus: epidemiology, clinical findings, treatment and prevention. Eur J Clin Microbiol Infect Dis. 2007; 26:785–92.CrossRefGoogle ScholarPubMed
Park, SD, Shon, HS, Joh, NJ. Vibrio vulnificus septicemia in Korea: clinical and epidemiologic findings in seventy patients. J Am Acad Dermatol. 1991; 24:397–403.CrossRefGoogle ScholarPubMed
Araujo, MR, Aquino, C, Scaramal, E, et al. Vibrio vulnificus infection in Sao Paulo, Brazil: case report and literature review. Braz J Infect Dis. 2007; 11:302–5.CrossRefGoogle ScholarPubMed
Porras-Cortes, G, Viana, JJ, Chavez-Mazari, B, Sierra-Madero, J. [Vibrio vulnificus in Mexico: a case report and review of the literature]. Rev Invest Clin. 1994; 46:495–8.Google Scholar
Frank, C, Littman, M, Alpers, K, Hallauer, J. Vibrio vulnificus wound infections after contact with the Baltic Sea, Germany. Euro Surveill. 2006; 11:E0608171.Google ScholarPubMed
Ruppert, J, Panzig, B, Guertler, L, et al. Two cases of severe sepsis due to Vibrio vulnificus wound infection acquired in the Baltic Sea. Eur J Clin Microbiol Infect Dis. 2004; 23:912–15.Google ScholarPubMed
Dalsgaard, A, Frimodt-Moller, N, Bruun, B, et al. Clinical manifestations and molecular epidemiology of Vibrio vulnificus infections in Denmark. Eur J Clin Microbiol Infect Dis. 1996; 15:227–32.CrossRefGoogle ScholarPubMed
Torres, L, Escobar, S, Lopez, AI, et al. Wound infection due to Vibrio vulnificus in Spain. Eur J Clin Microbiol Infect Dis. 2002; 21:537–8.Google ScholarPubMed
Paz, S, Bisharat, N, Paz, E, et al. Climate change and the emergence of Vibrio vulnificus disease in Israel. Environ Res. 2007; 103:390–6.CrossRefGoogle ScholarPubMed
Ralph, A, Currie, BJ. Vibrio vulnificus and V. parahaemolyticus necrotising fasciitis in fishermen visiting an estuarine tropical northern Australian location. J Infect. 2007; 54:e111–14.CrossRefGoogle ScholarPubMed
Tyring, SK, Lee, PC. Hemorrhagic bullae associated with Vibrio vulnificus septicemia. Report of two cases. Arch Dermatol. 1986; 122:818–20.CrossRefGoogle ScholarPubMed
Fujisawa, N, Yamada, H, Kohda, H, et al. Necrotizing fasciitis caused by Vibrio vulnificus differs from that caused by streptococcal infection. J Infect. 1998; 36:313–16.CrossRefGoogle ScholarPubMed
,CDC. Fact Sheet: Vibrio Vulnificus. 2005 [updated 2005; cited May 10, 2008]; Available from: http://www.cdc.gov/nczved/dfbmd/disease_listing/vibriov_gi.html.
Bross, MH, Soch, K, Morales, R, Mitchell, RB. Vibrio vulnificus infection: diagnosis and treatment. Am Fam Physician. 2007; 76:539–44.Google ScholarPubMed
Millership, SE, Chattopadhyay, B. Aeromonas hydrophila in chlorinated water supplies. J Hosp Infect. 1985; 6:75–80.CrossRefGoogle ScholarPubMed
Millership, SE, Stephenson, , Tabaqchali, S. Epidemiology of Aeromonas species in a hospital. J Hosp Infect. 1988; 11:169–75.CrossRefGoogle ScholarPubMed
Zhiyong, Z, Xiaoju, L, Yanyu, G. Aeromonas hydrophila infection; clinical aspects and therapeutic options. Rev Med Microbiol. 2002; 13:151–62.CrossRefGoogle Scholar
Ko, WC, Lee, HC, Chuang, YC, et al. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia. J Infect. 2000; 40:267–73.CrossRefGoogle ScholarPubMed
Lineaweaver, WC, Hill, MK, Buncke, GM, et al. Aeromonas hydrophila infections following use of medicinal leeches in replantation and flap surgery. Ann Plast Surg. 1992; 29:238–44.CrossRefGoogle ScholarPubMed
Gold, WL, Salit, IE. Aeromonas hydrophila infections of skin and soft tissue: report of 11 cases and review. Clin Infect Dis. 1993; 16:69–74.CrossRefGoogle ScholarPubMed
Kienzle, N, Muller, M, Pegg, S. Aeromonas wound infection in burns. Burns. 2000; 26:478–82.CrossRefGoogle ScholarPubMed
Adamski, J, Koivuranta, M, Leppanen, E. Fatal case of myonecrosis and septicaemia caused by Aeromonas hydrophila in Finland. Scand J Infect Dis. 2006; 38:1117–19.CrossRefGoogle ScholarPubMed
Smith, JA. Aeromonas hydrophila: analysis of 11 cases. CMAJ. 1980; 122:1270–2.Google ScholarPubMed
Siqueira, IC, Dias, J, Ruf, H, et al. Chromobacterium violaceum in siblings, Brazil. Emerg Infect Dis. 2005; 11:1443–5.CrossRefGoogle ScholarPubMed
Huffam, SE, Nowotny, MJ, , BJ. Chromobacterium violaceum in tropical northern Australia. Med J Aust. 1998; 168:335–7.Google ScholarPubMed
Midani, S, Rathore, M. Chromobacterium violaceum infection. South Med J. 1998; 91:464–6.CrossRefGoogle ScholarPubMed
Macher, AM, Casale, TB, Fauci, AS. Chronic granulomatous disease of childhood and Chromobacterium violaceum infections in the southeastern United States. Ann Intern Med. 1982; 97:51–5.CrossRefGoogle ScholarPubMed
Teoh, AY, Hui, M, Ngo, KY, et al. Fatal septicaemia from Chromobacterium violaceum: case reports and review of the literature. Hong Kong Med J. 2006; 12:228–31.Google ScholarPubMed
Sirisanthana, V. Fever with hemorrhagic and pustular blebs in 13 year old boy. Chiang Mai, Thailand: Department of Pediatrics, Faculty of Medicine, Chiang Mai University; 2008 [updated 2008; cited 2008]; Available from: http://www.med.cmu.ac.th/dept/pediatrics/06-interest-cases/ic-1-case1/case-1-chromo.htm.Google Scholar
Brown, KL, Stein, A, Morrell, DS. Ecthyma gangrenosum and septic shock syndrome secondary to Chromobacterium violaceum. J Am Acad Dermatol. 2006; 54(5 Suppl):S224–8.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×